Compare ARK Genomic Revolution ETF (ARKG) vs Kingsoft Cloud Holdings Limited (KC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Kingsoft Cloud Holdings Limited — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Kingsoft Cloud Holdings Limited trades at $10.6 (market cap $3.25B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Kingsoft Cloud Holdings Limited nearer its low. Which is the better fit depends on your goals.
| ARKG | KC | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $18.21 |
52-Week Low | $23.09 | $8.58 |
Market Cap | — | $3.25B |
Enterprise Value | — | $3.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Kingsoft Cloud (KC) trades at $10.91, up 4.2% today, with a bullish technical signal and strong analyst support (70% buy ratings). Recent earnings beats and accelerating revenue growth, driven by AI cloud demand, highlight operational momentum, though profitability remains negative. The stock is near resistance at $11, with RSI indicating potential overbought conditions short-term.
The outlook is cautiously optimistic given AI-driven growth potential and positive sentiment, but risks include persistent losses, high capital expenditure, and competitive pressures. Upside depends on margin improvement from AI investments, making KC a speculative growth play with significant execution risk.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Kingsoft Cloud Holdings Limited
Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.
Read more on KC →
